Knight Therapeutics Inc. (TSX:GUD) announces a share repurchase program. Under the normal course issuer bid, the company will repurchase up to 10,267,956 shares, representing 8.17% of its issued and outstanding share capital. The repurchased shares will be cancelled.

The bid will continue through on the earlier of the date on which purchases under the bid have been completed and July 13, 2022. As of June 30, 2021, the company had 125,664,970 shares issued and outstanding.